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Radiotherapy remains one of the corner stones in the treatment of various malignancies and often leads to an
improvement in overall survival. Nonetheless, pre-clinical evidence indicates that radiation can entail pro-metastatic
effects via multiple pathways. Via direct actions on cancer cells and indirect actions on the tumor
microenvironment, radiation has the potential to enhance epithelial-to-mesenchymal transition, invasion, migration,
angiogenesis and metastasis. However, the data remains ambiguous and clinical observations that unequivocally
prove these findings are lacking. In this review we discuss the pre-clinical and clinical data on the local and
systemic effect of irradiation on the metastatic process with an emphasis on the molecular pathways involved.
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Local invasion and distant metastasis are the cause of
death in most malignant tumors. Tumor response,
reflected by improved overall survival, and toxic side
effects, deteriorating quality of life, receive major atten-
tion in clinical trials investigating the main treatment
modalities used in cancer, namely, surgery, radiotherapy,
chemotherapy, targeted therapy and immunotherapy.
Yet, far less attention is paid to the effects of these treat-
ments on tumor progression as reflected by the meta-
static process.
Malignant tumors consist of cancer cells and tumor-
associated host cells, both participating in invasion and
distant metastasis. These cells form ecosystems at the
primary and at the metastatic site, mutually communi-
cating with one another and with stem cell-generating
organs such as the bone marrow. It is highly probable
that therapeutic manipulation of one ecosystem affects
the others, a phenomenon that needs to be analyzed in
view of the increasing cellular and molecular complexity
of therapy responses (Barker et al., 2015).
Metastatic cancer cells are released from the primary
tumor or from other metastases, at an undefined mo-
ment of its development, to arrive in the circulation and* Correspondence: nora.sundahl@ugent.be
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to survive and either remain dormant as micro-
metastases or grow to form macro-metastases (Mareel
et al., 2009a). There is good evidence that cancer cells
disseminate from the primary site early during tumor
development (Hosseini et al., 2016), yet it is difficult to
predict whether disseminated cancer cells are present at
the moment of treatment and, if so, where they reside.
Such cells are described as disseminated tumor cells
(DTC) (Sosa et al., 2014) or sometimes as circulating
tumor cells (CTC) (Kim et al., 2009). They can be awak-
ened from dormancy by local therapeutic manipulation
generating unfavorable distant effects.
Here we review the preclinical evidence on the effect
of irradiation on three main steps in the metastatic
process as proposed by Talmadge et al. (Talmadge &
Fidler, 2010), namely angiogenesis, motility and invasion,
and metastasis with an emphasis on the molecular path-
ways involved. Subsequently, the clinical evidence on
this subject is reviewed.Main text
Preclinical evidence
Angiogenesis
One of the first molecules implicated in enhancement of
distant metastasis after irradiation of the primary tumor
was angiostatin, produced by the primary tumor and
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ance towards pro-angiogenesis and growth of the lung
metastases (Table 1) (Camphausen et al., 2001). MolecularTable 1 In vitro and in vivo experiments investigating the influence
Radiation Vessel origin Host Re
Target Mode Dose Ty
Endothelial cells
C-ion 0.1–8 Gy HUVEC Transwell chamber Mi
Collagen Tu
kV 0.1–8 Gy Transwell chamber
Collagen Tu
nm 4 Gy HUVEC Matrigel Tu
nm 8 Gy HMEC Matrigel Inv
250 kV 6 Gy HUVEC Tissue culture plastic Wo
HUVEC Matrigel Tu
137 Cs 3 Gy HUVEC Matrigel Tu
125 kV 15 Gy HUVEC Tissue culture plastic Wo
6 MV 0.5 Gy HUVEC Wo
Cancer cells
6MV 10 Gy HUVEC Transwell/CM C6 Ch
6 MV 10 Gy CAM CAM/C6 an
HUVEC Matrigel/PC3 Inv
8 Gy HMEC Matrigel/CM B16 Inv
150 kV 10 Gy HMEC Matrigel/CM IOMM Tu
nm 8 Gy HMEC T. c. plastic/CM U251 Bra
CAF
15 MV 18 Gy HUVEC Transwell/CM CAF Mi
HUVEC Matrigel/CM CAF Tu
Inoculation site
50 kV 19 Gy CAM CAM/C6 An
6 MV 2 Gy SCID mouse subcutis HepG2 Mi
125 kV 20 Gy C57/Bl subcutis Matrigel plus FGF2 Mi
Matrigel plus VEGF Mi
6 MV 0.5 Gy nude mouse subcutis Matrigel plus FGF2 An
125 kV 20 Gy mammary fat pad. Mammary/AT1 Mi
Total body
220 kV 15 Gy C57/Bl aortic Tissue culture plastic Sp
6 MV 0.5 Gy zebra fish Embryo An
Tumor
250 kV 6 Gy C57/Bl6 subcutis LLC Mi
6MV 8 Gy C57/BL6 cerebrum ALTS1C1 Mi
SCID mouse subcutis SW410 Mi
Abbreviations: avb3, integrin; ALTS1C1, SV40 large T-transformed astrocytes
CAF, cancer-associated fibroblasts; CAM, chick chorioallantoic membrane; C-
synthase; FGF2, fibroblast growth factor 2; HepG2, human hepatoma cells; H
vein endothelial cells; IR/Ctrl, irradiated over unirradiated control target; IOM
metalloproteinase; MVD, microvessel density; nm, not mentioned; PC3, human
human colon carcinoma cells; t.c., tissue culture; TGFb, transforming growth fa
activator; VEGF, vascular endothelial growth factor; VEGFR, vascular endotheliacommunication between ecosystems is also witnessed by
the vasculogenic and pro-metastatic tumor bed effect as
discussed by Kuonen et al. (Kuonen et al., 2012d)of irradiation on angiogenesis
sult Molecular Ref
pe IR/Ctrl
gration < 1 αvβ3; MMP-2 (Takahashi et al., 2003)
be formation < 1
> 1
be formation 1
be formation 0.8 αvβ3 (Abdollahi et al., 2005)
asion 1 (Kaliski et al., 2005)
und healing migration 4 eNOS (Sonveaux et al., 2003)
be formation
be formation 0.8 αvβ3 (Albert et al., 2006)
und healing migration 0.6 (Imaizumi et al., 2010)
und healing migration > 1 VEGFR (Sofia Vala et al., 2010)
emotactic migration 2 MMP-2 & -9 (Parthymou et al., 2004)
giogenesis > 1 (Parthymou et al., 2004)
asion 1.9 (Abdollahi et al., 2005)
asion 2.4 MMP-2 (Kaliski et al., 2005)
be formation 1.4 uPA (Kargiotis et al., 2008)
nching 1.4 MMP-2 (Badiga et al., 2011)
gration 0.6 (Hellevik et al., 2013)
be formation 1 (Hellevik et al., 2013)
giogenesis > 1(48 h) (Polytarchou et al., 2004)
cro-vessel density > 1 VEGF
cro-vessel density 0.36 FGF2 (Imaizumi et al., 2010)
cro-vessel density 0.11 VEGF
giogenesis > 1 (Sofia Vala et al., 2010)
cro-vessel density 0.44 (Kuonen et al., 2012b)
routing 0.11 TGFΙβ (Imaizumi et al., 2010)
giogenesis > 1 (Sofia Vala et al., 2010)
cro-vessel density > 1 (Sonveaux et al., 2003)
cro-vessel density > 1 (Wang et al., 2013)
cro-vessel density 2 (Timaner et al., 2015)
; B16, mouse melanoma cells; C57/BL, mouse strain; C6, rat glioma cells;
ion, carbon ion; CM, conditioned medium; eNOS, endothelial nitric oxide
MEC, human microvascular endothelial cells; HUVEC, human umbilical
M, human meningioma cells; LLC, Lewis lung cancer cells; MMP, matrix
prostate cancer cells; pcb, polycarbonate transwell chamber; SW410,
ctor beta; U252, human glioma cells; uPA, urokinase-type plasminogen
l growth factor receptor; WH, wound healing
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hypoxic primary tumor ecosystem. Hypoxia stimulates
hypoxia inducible factor (HIF)-dependent expression of
CXCL12 and KITL promoting mobilization from the bone
marrow and recruitment to primary tumor and metastatic
sites of CXCR4+CD11b+ bone marrow-derived cells and
KITbCD11b+ cells assisting vasculogenesis and metastasis
respectively (Kuonen et al., 2012d). Recruitment of
CD11b+CD11c+ myelomonocytic cells to the metastatic
site was also found after whole thorax irradiation at a dose
of 15 Gy of mice that significantly enhanced seeding and
metastatic growth of intravenously injected cancer cells.
Such treatment was associated with upregulation of
invasion- and inflammation-promoting soluble factors,
such as matrix metalloproteinase 2 (MMP2), its activator
MMP14, tissue inhibitors of matrix metalloproteinase 2
(TIMP2), chemokine ligand 2 (CCL2), and urokinase-type
plasminogen activator (uPA), the latter two being linked
to the recruitment of the monocytic cells. Intravenous in-
jection of multipotent vascular wall-resident mesenchymal
stromal cells (MSCs) counteracted lung inflammation and
metastasis by an as yet unknown mechanism (Klein et al.,
2016). Translation of the latter data to the clinical situ-
ation is difficult, since whole thorax irradiation of 15 gray
(Gy) is not applied in radiotherapy. Nevertheless one
should consider that induction of lung metastases in mur-
ine models does occur upon total body irradiation at doses
as low as 0.3 Gy (Sofia Vala et al., 2010) and upon partial
thorax irradiation at doses (10 Gy) (Feys et al., 2015) that
can be received by the lungs during radiotherapy for
neighboring organs such as the esophagus.
The pro-angiogenic effect on endothelial cells by the ir-
radiation of cancer cells was demonstrated by the subcuta-
neous inoculation of cancer cells, irradiated or not, in
mice (Chung et al., 2006) or onto the chick chorioallontoic
membrane (CAM) (Parthymou et al., 2004) with evalu-
ation of microvessel density. Increased angiogenesis was
observed even when the growth of the cancer cells was
reduced after a dose of 40 Gy. In vitro coculture of endo-
thelial cells with irradiated cancer cells in the Matrigel
invasion assay without direct contact between both cell
types pointed to a role for soluble mediators (Abdollahi
et al., 2005). Implication of such mediators was confirmed
using conditioned media from irradiated as compared to
unirradiated cancer cells in assays for capillary tube for-
mation (Kargiotis et al., 2008; Badiga et al., 2011), chemo-
tactic migration (Parthymou et al., 2004) and Matrigel
invasion (Kaliski et al., 2005). In contrast, conditioned
medium from irradiated fibroblasts isolated from human
lung cancer reduced transwell migration of human umbil-
ical vein endothelial cells (HUVEC) and left tube forma-
tion on Matrigel unchanged (Hellevik et al., 2013).
Irradiation of a Matrigel plug, a surrogate implant mim-
icking the primary tumor, 10 days after subcutaneousimplantation in mice stimulated its colonization by capil-
laries. This finding was confirmed by the observation of
enhanced infiltration of CD31-positive cells after local
irradiation of Lewis lung carcinoma-bearing mice. Ex vivo
irradiation-mediated enhancement of angiogenesis was
demonstrated by capillary sprouting from arterioles iso-
lated from these mouse tumors (Sonveaux et al., 2003).
Also irradiation of glioma at 10 and 40 Gy on the chick
CAM induces angiogenesis when administered 48 h after
inoculation (Parthymou et al., 2004). After ablative doses,
restoration of the vasculature in experimental glioblast-
oma by vasculogenesis is mediated by irradiation-induced
influx of bone marrow derived monocytes and macro-
phages, which eventually leads to tumor regrowth (Kioi
et al., 2010a; Russell & Brown, 2013a; Wang et al., 2013).
Normalization of the vasculature occurred after irradi-
ation at a dose of 5 times 5 Gy of a subcutaneous colorec-
tal tumor in a rat where dynamic contrast-enhanced
magnetic resonance imaging with gadomelitol showed
reduction of neovascular leakage, enhanced tissue oxygen-
ation and enhanced expression of vascular endothelial
growth factor (VEGF) (Ceelen et al., 2006).
Irradiation of endothelial cells revealed direct anti-
angiogenic as well as pro-angiogenic effects, which
seems to be dependent on the irradiation dose. At doses
between 2 and 15 Gy, irradiated HUVEC provoked acute
(within 24 h) apoptosis and inhibited survival, prolifera-
tion, capillary tube formation on Matrigel and invasion
through Matrigel (Abdollahi et al., 2005; Albert et al.,
2006; Imaizumi et al., 2010). Inhibition of subsequent
angiogenesis from quiescent endothelial cells about 1 week
after irradiation was demonstrated in various in vivo and
in vitro assays (Imaizumi et al., 2010). A lower dose (0.5
and 0.8 Gy) may exert a pro-angiogenic activity as shown
by enhanced wound healing migration of HUVEC (Sofia
Vala et al., 2010). Indeed, hypo-fractionated irradiation
delivering more than 5 Gy per fraction destroys the micro-
vasculature more efficiently than conventional irradiation
(De Wolf et al., 2015). At biologically equivalent doses,
photons stimulate migration of ECV304 human endothe-
lial cells whereas carbon-ions work inhibitory. In line with
this, capillary tube formation was abolished by carbon-
ions at doses, at which it was conserved after photon
irradiation (Takahashi et al., 2003).
Total body irradiation (TBI) or irradiation of host sites
or sites of cancer cell implantation influenced spontan-
eous or cancer cell-induced angiogenesis. TBI of C57/BL
mice at a high dose of 15 Gy inhibited ex vivo aortic ring
formation (Imaizumi et al., 2010); at a dose smaller than
1 Gy, TBI enhanced splenocyte-induced angiogenesis in
mice (Kaminski et al., 1983) and spontaneous angiogen-
esis in transgenic embryonic Zebra fish (Sofia Vala et al.,
2010). Similarly, local irradiation was pro-angiogenic at a
dose of 0.3 Gy (Sofia Vala et al., 2010) whereas higher
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angiogenesis in the Matrigel plug assay (Imaizumi et al.,
2010; Kuonen et al., 2012b). However, this inhibition of
angiogenesis does not necessarily work anti-metastatic.
In a model mimicking local breast cancer relapse after
radiotherapy, irradiation (20 Gy) of the mouse mammary
gland before injection of syngeneic AT1 cells reduced
microvessel density, which was accompanied by en-
hanced local invasion and metastasis to lymph nodes,
lungs and liver (Kuonen et al., 2012b).
Apart from the irradiation dose, the timeline also in-
fluences the angiogenic response. Implantation of C6 gli-
oma cells on the chick CAM following irradiation
entailed inhibition of vessel formation during the first
hours; which was followed by attraction of new vessels
within the next 48 h (Polytarchou et al., 2004).
The above summarized experiments provide argu-
ments to accept that irradiation of cancer cells or of ele-
ments of the tumor microenvironment may support or
destroy the tumor vasculature and that both support
and destruction may enhance invasion and metastasis.
Invasion
Homotypic cell-cell adhesion The homotypic cell-cell
adhesion molecule E-cadherin was identified as one of the
first invasion-suppressors. Its downregulation engages
epithelial mesenchymal transition (EMT) in embryonic
development and in cancer (Mareel et al., 1993). Irradi-
ation has been shown to induce EMT via the upregulation
of integrin, MMP9 and MMP2 and the downregulation of
E-cadherin and cytokeratin 19 (Rajput et al., 2015a), as
reviewed in detail by Lee et al. (Lee et al., 2017a) Irradi-
ation causes EMT in cancer cells from various origins,
such as prostate (Chang et al., 2013a), esophagus (He et al.,
2015a), lung (Ho et al., 2010a; Liu et al., 2014c; Zhou et al.,
2012; Zhao et al., 2017), colorectum (Kawamoto et al.,
2012; Timaner et al., 2015), breast (Rajput et al., 2015;
Kim et al., 2015; Kuo et al., 2015a; Yuan et al., 2015a; Zhou
et al., 2011a), uterine cervix (Yan et al., 2013a), stomach
(Zhang et al., 2015b), and glioma (Park et al., 2012). This
irradiation-induced EMT is also accompanied by increased
cell migration and invasion (He et al., 2015a; Tsukamoto
et al., 2007). Via interaction with multiple pathways, the
transcription factors zinc finger protein SNAI1 (Snail) and
zinc finger E-box-binding homeobo× 1 (ZEB1) appears as
key in this irradiation-induced EMT (Fig. 1) (Lee et al.,
2017a). Phosphorylation by kinases and dephosphoryla-
tion by phosphatases play a role in the fine tuning of
irradiation-modulated EMT. The serine-threonine kinase
glycogen synthase kinase-3β (GSK-3β) phosphorylates β-
catenin so directing it to the ubiquitin proteasome degrad-
ation complex. Failure of GSK-3β leads to accumulation
of β-catenin and translocation to the nucleus where it
serves as a transcription factor in association with T-cellfactor (TCF). Downstream genes of the β-catenin/TCF
complex include AXIN2 (encoding axis-inhibition protein
2), FZD7 (encoding Frizzled 7), HNF1A, CCND1 (encod-
ing cyclin D1), CD44, GCSF (encoding granulocyte-
colony stimulating factor (G-CSF)), VEGF, MMP2, and
MMP9, all implicated in invasion and metastasis. At the
other side of the balance, the serine-threonine protein
kinase tank-binding kinase-1 (TBK-1), a member of the
inhibitor κB (IκB) kinase-related kinase family, activates
GSK-3β, in this way attenuating irradiation-induced
EMT (Liu et al., 2014c). Fractionated irradiation using
sublethal doses administered over a period of 2 months
and clonal selection for radioresistant esophageal can-
cer cells leads to downregulation of the phosphatase and
tensin homolog (PTEN) and upregulation of phosphoino-
sitide 3-kinase (PI3K) which is linked with inactivation of
GSK-3β and is associated with elevated Snail protein,
which enhances EMT (He et al., 2015a). Furthermore, the
activation of PI3K and subsequent stabilization of β-
catenin in non-small-cell lung cancer cells, via the admin-
istration of 2 Gy on 3 consecutive days, promotes G-CSF,
which in turn instigates EMT through JAK-STAT signal-
ing pathways (Cui et al., 2015a).
Migration Migration of invading cells is executed
through reorganization of the actin cytoskeleton and
directed by the assembly/disassembly equilibrium of the
cytoplasmic microtubule complex. By alteration of the
biomechanical properties and the organization of the
actin cytoskeleton, photon irradiation can promote inva-
sion and migration of cancer cells, as observed in
various cell lines via wound-healing assays, transwell mi-
gration assays and spheroid migration assays (see Table 2)
(Kargiotis et al., 2008; Rajput et al., 2015a; Zhao et al.,
2017; Kawamoto et al., 2012; Zhou et al., 2011a; Zhang
et al., 2015b; Gu et al., 2015a; Tsutsumi et al., 2009;
Nalla et al., 2010; De Bacco et al., 2011a; Fujita et al.,
2011; Pickhard et al., 2011a; Fujita et al., 2012; Burrows
et al., 2013; Ghosh et al., 2014; Murata et al., 2014; Fujita
et al., 2015a; Nakayama et al., 2016; Fujita et al., 2014a;
Fujita et al., 2015b; Zhai et al., 2006a; Zheng et al., 2015;
Ohuchida et al., 2004). Carbon-ion irradiation can also
stimulate invasion via the same PI3K pathway in certain
cell lines. However, in several cell lines it was observed
that carbon-ion irradiation inhibits migration and in-
vasion via the ubiquitin-proteasome-mediated degradation
of guanosine triphosphatase (GTP)-bound Rac1 and
GTP-bound RhoA (Fujita et al., 2015a; Fujita et al.,
2015b; Akino et al., 2009). Of note, in the majority of
experiments migration and invasion were affected in the
same direction by irradiation; however, an opposite effect
was observed in two pancreas cancer cell lines (Qian
et al., 2003) and in one breast cancer cell line (Rajput
et al., 2015a) with hampered migration and improved
Fig. 1 Molecular pathways regulating cellular activities implicated in radiation -enhanced invasion and metastasis. Modified after Zhai et al., (2006b),
Chargari et al., (2013), He et al., (2015b) and Lee et al., (2017b), with data from: Ahmed et al., (2013b); Asuthkar et al., (2011); Bastos et al., (2014); Chang
et al., 2013b; Cheng et al., (2006b); Cho et al., (2016b); Cui et al., (2015b); de Marcondes (2017); Dong et al., (2015b); Eke & Cordes, (2015b); Fujita et al.,
(2014b); Fujita et al., (2015c); Gu et al., (2015b); He et al., (2015b); Ho et al., (2010b); Kang et al., (2013); Yan et al., (2013b); Kim et al., (2016); Kuo et al.,
(2015b); Liu et al., (2014b); Park et al., (2006b); Pichard et al., (2011b); Rajput et al., (2015b); Yuan et al., (2015b); Zhai et al., (2006b); Zhou et al., (2011b).
Green, red and white boxes are secretory, transmembrane receptor and intracellular signaling molecules respectively. The glowing box is a
mitochondrion; the double line is DNA. Abbreviations: Akt, protein kinase B; AP1, activator protein 1; BclxL, B-cell lymphoma-extra large; Bmi-1, B cell-
specific Moloney murine leukemia virus integration site 1; β-CTN, beta-catenin; CRK, CT10 regulator of kinase; CXCL12, C-X-C motif chemokine 12;
CXCR4, C-X-C chemokine receptor type 4; Dlx-2, distal-less homeobox-2; ECM, extracellular matrix; EGF, epidermal growth factor; EGFR, epidermal
growth factor receptor; EphA4, ephrin A 4; ERK, extracellular signal-regulated kinase; FAK, focal adhesion kinase; GAB1, GRB2-associated-binding protein;
GADD45a, Growth Arrest and DNA Damage inducible Alpha; GCSF, granulocyte colony stimulating factor; GCSFR, granulocyte colony stimulating factor
receptor; GIRDIN, Guanine nucleotide-binding protein α subunit -interacting vesicle-associated protein; Gli1, Glioma-associated oncogen; GRB2, Growth
factor receptor-bound protein 2; GSK3β, glycogen synthase kinase 3 beta; HGF, hepatocyte growth factor; HIF-1, hypoxia-inducible factor-1; IGF, insulin-
like growth factor; IGFR, insulin-like growth factor receptor; IL-6, interleukin 6; ILK, integrin-linked kinase; JAK, Janus kinase; LAP-β1, latency-associated
peptide of TGF-β; MEK, mitogen-activated kinase kinase; MET, tyrosine-protein kinase Met; MMP, matrix metalloproteinase; mTOR, mechanistic target of
rapamycin; NF-κB, nuclear-factor kappa-light-chain-enhancer of activated B cell; Nrf2, Nuclear factor E2 related factor 2; NSB1, Nijmegen breakage
syndrome 1; p53, Tumor protein p53; PAI-1, plasminogen activator inhibitor 1; PAK1, p21- activated kinase 1; PI3K, phosphatidylinositol 3-kinase; PTEN,
phosphatase and tensin homolog; Rac, Ras-related C3 botulinum toxin substrate; RACK1, receptor for activated C kinase 1; RAF, Rapid Accelerated
Fibrosarcoma; RAP, Ras-proximate; RAS, Rat sarcoma; RhoA, Ras homolog gene family member A; RNS, reactive nitrogen species; ROS, reactive oxygen
species; Src, sarcoma family kinase; SMAD, small and mothers against decapentaplegic; Smo, Smoothened; SOS, Son of Sevenless; STAT, signal transducer
and activator of transcription; TCF, T-cell factor; TGF-β, transforming growth factor beta; TKB-1, tank-binding kinase-1; TSP1, Trombospondin 1; TβRII, TGF-β
type II receptor; Wnt, Wingless-related integration site; ZEP1, Zinc finger E-box-binding homeobo× 1
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in organ culture where normal brain tissue fragments
were confronted with aggregates of cancer cells, mimick-
ing local invasion as it occurs in gliomas (Wick et al.,
2002; Wild-Bode et al., 2001).Various elements of the ecosystem served as success-
ful targets for irradiation-mediated enhancement of in-
vasion. Cancer cells, mostly issued from cell lines, were
target in most studies (Table 2); host cells were targets in
some experiments. For instance, irradiation of reconstituted
Table 2 Effect of radiation on the invasion of cancer cells in Matrigel-coated two-compartment chambers in vitro
Cancer cells Radiation Invasion Molecular Inhibitor Ref
Origin Code Mode Dose IR/Ctrl
Glioblastoma U87MG; LN-18; LN-229 137Cs 6 Gy 5; 3; 3.7 MMP; BcL-2 (Wild-Bode et al., 2001)
LN-229; U87MG 137Cs 6 Gy 1.5; 1.7 αvβ3 integrin temozolomide (Wick et al., 2002)
A-172; U-138 240 kV 8 Gy 0.07; 1 (Cordes et al., 2003)
U251; U373; LN18;
LN428
137Cs 5 Gy 1.5; 1 EGFR/Src (Park et al., 2006a)
UN3; GM2 nm 6 Gy 2.2; 2.2 IGF-1/Rho (Zhai et al., 2006a)
U87 MV 3 Gy 1.7 Wnt/βCTN XAV939 (Dong et al., 2015a)
U251 200 kV 10 Gy 1.3 MMP/TIMP Paputilone (Furmanova-Hollenstein
et al., 2013)
C6L* 137Cs 3 Gy 2 EMT markers (Park et al., 2012)
Meduloblastoma DA0Y; D283 RS 2000 7 Gy 1.5; 1.5 uPAR; β1/FAK (Nalla et al., 2010)
Neuroblastoma SH-EP; SK-N-SH; SH-SY5Y;
SK-N-AS; NLF
200 kV 6 Gy 4; 2.5; 4; 1; 1 HGF/Met (Schweigerer et al., 2005)
Meningioma IOMM-Lee 150 kV 5 Gy 1.8 uPAR (Kargiotis et al., 2008)
Pancreatic Ca Panc-1; Suit-2; Hs766T 137Cs 10 Gy 2.0; 1.6; 1 MMP-2 CGS27023A (Qian et al., 2002)
Panc-1; AsPC-1; Suit-2 137Cs 10 Gy 1.5; 1.3; 1.4 HGF/Met NK4 (Qian et al., 2003)
PANC-1; AsPC-1; BxPC-3;
MIAPaCa-2
C-ion 2 Gy 4; 0.5; 0.3; 0.1 MMP2 GM6001 (Fujita et al., 2012)
PANC-1 C-ion 2 Gy 2.5 NO/PI3K Table 1 (Fujita et al., 2014a)
AsPC-1, BxPC-3,
MIAPaCa-2
C-ion 2 Gy 0.01 Rac1/RhoA (Fujita et al., 2015a)
MIA-PaCa; PANC-1 X-ray 4 Gy 3; 1.6 MMP-2 GM6001 (Fujita et al., 2011)
Lung SCC EBC-1 C-ion 2 Gy 0.6 (Akino et al., 2009)
EBC-1 4MV 2 Gy 1.2 (Akino et al., 2009)
Lung Adenoca A549 C-ion 2 Gy 0.4 ANLN (Akino et al., 2009)
A459 4 MV 2 Gy 0.5 (Akino et al., 2009)
A459 137Cs 10 Gy 2.5 Bcl-xl/STAT3 (Ho et al., 2010a)
A549 C-ion 10 Gy 0.2 PI3K/Akt (Ogata et al., 2011)
4 Mv 10 Gy 0.5
A549 60Co 2 Gy × 1.5 MMPs (Zhou et al., 2012)
A459; H1299 MV 4 Gy 0.7; 0.7 TBK1 MG132 (Liu et al., 2014c)
A549; HT1299 137Cs 3 × 2 Gy 1.5; 1.5 G-CSF (Cui et al., 2015a)
H1299; A459; H460 MV 2 Gy 1.5; 2; 1.2 CXCR4 (Gu et al., 2015a)
A549 137Cs 10 Gy × 1.8 EGFR Gefitinib; PPA (Cho et al., 2016a)
A549; H460 X-ray 4 Gy × 1.5; × 1.4 Nrf2/Notch (Parthymou et al., 2004;
Zhao et al., 2017)
LLC-LM* 60Co 7,5 Gy × 3,5 MMP9 (Chou et al., 2012)
Mammary Ca MCF7 60Co 2 Gy × 1.4 TGF- β (Zhou et al., 2011a)
MCF7; SKBR3 137Cs 3 × 2 Gy × 5; 4.3 SRC/PI3K (Kim et al., 2015)
MCF7 137Cs 5 Gy × 2 NBS1/HIF-1a (Kuo et al., 2015a)
MCF7; MDA-MB-231 5 Gy 1.7 TGF- β Thymoquinone (Rajput et al., 2015a)
MDA-MB-231 5 Gy × 2 (Vilalta et al., 2014)
MCF7 137 Cs 2 Gy × 1.6 EMT histamine (Galarza et al., 2016)
MDA-MB-231, 6 MV 10 Gy × 2 Met PHA665752 (De Bacco et al., 2011a)
MCF-7 X-ray 20 × 1 Gy × 5 Snail; twist (Zhang et al., 2011)
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Table 2 Effect of radiation on the invasion of cancer cells in Matrigel-coated two-compartment chambers in vitro (Continued)
Cancer cells Radiation Invasion Molecular Inhibitor Ref
Origin Code Mode Dose IR/Ctrl
4 T1* 137Cs 20 Gy × 3.5 GM-CSF (Vilalta et al., 2014)
Prostatic Ca PC-3; DU145 6 MV 5 × 2 Gy ×2 PI3K/AKT BEZ235 (Chang et al., 2013)
Oral Ca OECM1 137Cs 5 Gy × 2.4 (Kuo et al., 2015a)
Esophageal.
.SCC
KYSE-150 150 kV 37 Gy × 1.3 PTEN (He et al., 2015a)
TE-9 125 kV 2 Gy 15 TGF- β metformin (Nakayama et al., 2016)
Hepatoma HepG2; Huh7; 60Co 7.5 Gy × 3 PI3K (Cheng et al., 2006a)
Colon Ca CaR1; DLD1 100 kV 5 Gy 6.5; 4.3 EMT (Kawamoto et al., 2012)
HCT116 137Cs 4 Gy × 1.7 MMP (Speake et al., 2005)
HT29 137Cs 5 Gy 2 βCTN/TCF (Bastos et al., 2014)
Cervical Ca Siha; C33A X-ray 75 Gy × 3; 3 NF-kB p65 (Yan et al., 2013a)
Fibrosarcoma HT180 proton 2 Gy 0.2 MMP-2 (Ogata et al., 2005)
C-ion 2 Gy 0.2 MMP-2
4 MV 2 Gy × 1.6 or 1 MMP-2 GM6001
HT1080 137Cs 4 Gy × 1.5 MMP-2 & 9 (Speake et al., 2005)
HT180 200 kV 2 Gy × 1.5 MMP/TIMP patupilone (Furmanova-Hollenstein
et al., 2013)
Melanoma B16* 137Cs 8 Gy × 3 MMP-2 Metastat (Kaliski et al., 2005)
Most cell lines are human, except cell lines marked by an asterisks which are rodent. Inhibitors comprise agents that were used clinically, namely: BEZ235, an
imidazoquinolone derivative and an inhibitor of PI3K and mTOR; CGS27023A, a matrix metalloproteinase inhibitor and anti-metastatic agent; Gefitinib, tyrosine
kinase inhibitor targeting EGFR; GM6001, a broad -spectrum matrix metalloproteinase inhibitor known as galardin; Histamine, a biogenic amine that targets four
(H1–H4) histamine subtypes G-protein coupled receptors (GPCR); Metastat, a chemically modified tetracycline and inhibitor of gelatinase and MMP; Metformin, an
anti-diabetic; MG132, a specific proteasome inhibitor; NK4, a four-kringle antagonist of hepatocyte growth factor and an angiogenesis inhibitor; Patupilone, a
microtubule stabilizing drug; PHA665752, an ATP-competitive small-molecule inhibitor of the tyrosine kinase c-Met; PPA, Podophyllotoxin acetate, a microtubule
inhibitor and a spindle poison; temozolomide, an alkylating chemotherapeutic drug; Thymoquinone, a regulator of NF- kB and extracellular signal-regulated kinase
(ERK) signaling pathways. Abbreviations: Akt, protein kinase B; ANLN, human homologue of anailin; b1, beta1 integrin subunit, b-CTN, beta-catenin; BcL-2, B-cell
lymphoma 2; BclxL, B-cell lymphoma-extra large; C-ion, carbon-ions; Ca, carcinoma; Co, cobalt; Cs, cesium; Ctrl, unirradiated control; CXCR4, C-X-C chemokine
receptor type 4; EGFR, epidermal growth factor receptor; EMT, epithelial-to-mesenchymal transition; FAK, focal adhesion kinase; GCSF, granulocyte colony
stimulating factor; Gy, gray; HGF, hepatocyte growth factor; IGF1, insulin-like growth factor-1; Met, tyrosine-protein kinase Met; MMP, matrix metalloproteinases;
nm, not mentioned; NO, nitric oxide; Nrf2, Nuclear factor E2 related factor 2; PI3K, phosphatidylinositol 3-kinase; PPA, Podophyllotoxin acetate; Rho, Ras homolog
gene family member; SCC: squamous cell carcinoma; Src,sarcoma family kinase; STAT, signal transducer and activator of transcription; TBK1, tank-binding kinase 1;
TCF, T-cell factor; TGFb, transforming growth factor beta; TIMP, tissue inhibitor of matrix metalloproteinase; TGF-b, transforming growth factor beta; uPAR,
urokinase-type plasminogen activator receptor; Wnt, Wingless-related integration site; XAV 939, a selective β-catenin-mediated transcription inhibitor
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HT1080 sarcoma cells (Heisel et al., 1984). Irradiated EA.
hy926 endothelial cells enhanced the migration of human
MDA-MB-231 and murine 4 T1 breast cancer cells (Feys
et al., 2015). Enhanced colon cancer cell adhesion to
HUVEC was obtained when both elements were irradiated
(Hamalukic et al., 2011a). Variations in the elements of the
ecosystems and of the experimental manipulations influ-
enced irradiation-enhancement of invasion-related cellular
activities, though various authors did not always obtain the
same result.
The invasive response to irradiation seems to be dose-
dependent. Dose-response curves were registered for single
doses between 1 Gy and 10 Gy (Burrows et al., 2013; Park
et al., 2006a). Maximal enhancement of invasion-related
activities was obtained at single doses around 4 to 5 Gy
(Park et al., 2012; Fujita et al., 2011). In most of these ex-
periments with sublethal doses, proliferation was inhibited,
a situation that is known to be permissive for migrationand invasion (Storme & Mareel, 1984). Proliferation was
unchanged in human glioma cells at the lower dose of
20 cGy that led to enhanced wound-healing migration
(Ghosh et al., 2014). To obtain more invasive radioresistant
cell lines, doses varied largely: 1 × 6 Gy (Su et al., 2012);
1 × 10 Gy (Tsutsumi et al., 2009); 5 × 2 Gy daily (Chang
et al., 2013); 20 × 1 Gy (Zhang et al., 2011) and 35 × 2 Gy
(He et al., 2015a; Yan et al., 2013a). In the experiments by
Zhang et al. cells were tested shortly after irradiation, in
contrast to the others where irradiation occurred weeks
before testing in the in vitro ecosystem as they were
maintained and selected to obtain resistant cell lines
(Zhang et al., 2011). The pro-invasive effect of 10 Gy
on lung adenocarcinoma cells was transient with en-
hancement after 16 and 24 h but not after 48 and
72 h (Ho et al., 2010a).
As to the organ of origin, Fujita et al. compared 31 cell
lines irradiated or not with a single dose and found
qualitative (e.g. stimulation of inhibition of invasion) and
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their invasive response, that were not related to their
organ of origin (Fujita et al., 2015b). In the same experi-
mental series, differences in invasive response to irradi-
ation were found between cancer cells of similar organ
of origin, namely glioma (Cordes et al., 2003), lung
(Akino et al., 2009), thyroid (Burrows et al., 2013), and
breast cancer (Paquette et al., 2011). Opposite effects of
irradiation were described for the same cell lines also by
different authors, e.g. MCF7 breast cancer cells (Kim
et al., 2015; Paquette et al., 2011; Galarza et al., 2016),
pancreatic cancer cells (Fujita et al., 2012; Qian et al.,
2002), glioblastoma cells (Wick et al., 2002; Wild-Bode
et al., 2001; Cordes et al., 2003) and lung cancer cells
(Zhao et al., 2017; Zhou et al., 2011a; Gu et al., 2015a;
Jung et al., 2007; Cho et al., 2016a; Ogata et al., 2011;
Liu et al., 2014a). Published details of these experiments
did not permit us to conclude which variables were re-
sponsible for such opposite results. With regard to the
mode of irradiation, no systematic differences were
noted between photons with lower (250 kV) as com-
pared to higher (MV) energy (Table 2). Heavy particles
(carbon-ions) were clearly different in as much as they
inhibited invasion at biologically equivalent or lower doses
that lead to enhancement with photons (Fujita et al., 2012;
Fujita et al., 2015a; Fujita et al., 2015b). This was also dem-
onstrated in matched experiments using the same cell
types and the same cellular activities as an endpoint
(Ogata et al., 2005; Rieken et al., 2012; Stahler et al., 2013),
though there are exceptions that showed stimulation
(Murata et al., 2014) or inhibition (Akino et al., 2009;
Ogata et al., 2011) for both modes of irradiation.
Epidermal growth factor receptor (EGFR)-positive
breast cancer cells, but not negative ones, were induced to
invade by ionizing radiation in a reactive oxygen species
(ROS)-dependent manner (Kambach et al., 2014). In
human lung adenocarcinoma cells (A549), ROS function
as intracellular second messengers that participate in the
activation of intracellular signaling pathways and, there-
fore, may mediate ligand-independent and rapid (within
5 min) phosphorylation of cell surface receptors, like
EGFR (Lee et al., 2008). Kinetic analysis showed that the
non-receptor kinase Src was transiently activated within
30 min of irradiation at a dose of 10 Gy, whereas ErbB2
phosphorylation began to increase after 60 min and was
maintained for at least 24 h. The signal transducer and ac-
tivator of transcription factor 3 (STAT3) was observed to
be phosphorylated also 30 min after irradiation, preceding
the accumulation of the Bcl-2 anti-apoptotic family
member B cell lymphoma-extra large (Bcl-XL) and
stimulation of invasion (Table 2) (Ho et al., 2010a). In
the latter experiments, applying a single exposure of
10 Gy, irradiation-induced STAT3 phosphorylation was
not stable, and decreased with continued incubation,reflecting a downregulation of malignant signals. In-
deed, Bcl-XL and EMT markers were restored to their
original levels when incubation continued for up to
48–72 h and invasion did no longer differ from that of
unirradiated controls. It would be interesting to know
whether or not this reversibility could be overcome by
a multiple exposures as it is applied in fractionated
radiotherapy. Curiously and in line with the results on
invasion, carbon-ions do not affect EGFR activity or
the downstream signaling effectors (Fujita et al., 2015b;
Stahler et al., 2013).
Cell-matrix adhesion Cell-matrix adhesion is mediated
by transmembrane receptors, called integrins that bind to
the extracellular matrix and signal intracellularly. Integrins
contribute to invasion and metastasis by regulating cell
motility, localization and activity of MMPs, as well as cell
survival (Desgrosellier & Cheresh, 2010). Integrins are
linked to the EGFR through integrin-linked kinase (ILK)
and particularly interesting new cysteine-histidine-rich 1
(PINCH1) forming multiprotein and multifunctional
complexes cooperatively promoting invasion (Li et al.,
2013; Eke & Cordes, 2015a). At their extracellular end
αvβ5 integrins cooperate with the matricellular protein
cysteine-rich angiogenic inducer 61 (CYR61) mediating
the pro-metastatic effect of tumor bed irradiation
(Monnier et al., 2008). In vitro and in vivo experiments
(Tables 2 and 3) show that invasion-enhancing doses of
irradiation upregulate integrins as well as phosphorylate
focal adhesion kinase (FAK) and paxillin, which are
critical mediators of cell migration (Tsutsumi et al.,
2009; Nalla et al., 2010; Gogineni et al., 2011). In
pancreatic cancer cells upregulation of integrins was
ascribed to increased transcription and to increased
postendocytic recycling (Yao et al., 2011). A striking
correlation between glioma cell migration and upregu-
lation of αvβ5 integrin is described by Rieken et al.
(Rieken et al., 2011) In contrast to photons, carbon-
ions impaired migration through down-regulation of
cell surface integrin expression. Also MMPs are acti-
vated upon irradiation-enhanced integrin expression,
suggesting an interplay between the mesenchymal form
of migration and cell matrix degradation (Wild-Bode
et al., 2001; Yao et al., 2011; Vehlow & Cordes, 1836). A
forward feedback survival pathway was discovered in
radioresistant breast cancer cells, where irradiation-
stimulated β1 integrin causes NF-κB to bind to the pro-
moter region of β1 integrin and to transactivate it
(Ahmed et al., 2013a).
Proteolysis Breakdown of extracellular matrix (ECM) by
invasive cells is mediated by lytic enzymes such as
MMP2, MMP9 and membrane-bound MMP-1 (MT1-
MMP). These enzymes act in balance with inhibitors
Table 3 Effect of radiation on local invasion or metastasis of rodent and human cancer cell lines as tested in syngeneic and in
xenogeneic mice respectively
Radiation Inoculum Score (Ir/Ctrl) Molecular Ref
Target Mode Dose Code Origin Site
Syngeneic
Cancer cells
137 Cs 3 Gy 9 L glioma intracaranial 40d αvβ3 (Wild-Bode et al., 2001)
C-ion 5 Gy LM8 osteosarcoma subcutaneous 0.6 (Ogata et al., 2005)
C-ion 5 Gy LM8 osteosarcoma intravenous 0.4 (Ogata et al., 2005)
4 MV 10 Gy LM8 osteosarcoma subcutaneous 1 (Ogata et al., 2005)
4 MV 10 Gy LM8 osteosarcoma intravenous 0.4 (Ogata et al., 2005)
nm 3 Gy 9 L glioma intracaranial 2.4d IGFR1 (Zhai et al., 2006a)
CAF
137 Cs 10 Gy Suit_2/CAF pancreatic ca intrapancreas 2.5d Met (Ohuchida et al., 2004)
nm 4 Gy PC/CAFCM Pancreatic ca intravenous 4 CXCL12 (Li et al., 2016a)
Mammary f. p.
MV 4 × 6 Gy D2A1/FUCCI mammary ca mammary f.p. 1.8d COX2; IL6 (Bouchard et al., 2013)
MV 4 × 6 Gy D2A1/FUCCI mammary ca mammary f.p. 2c (Bouchard et al., 2013)
MV 4 × 6 Gy D2A1/FUCCI mammary ca mammary f.p. 2.4 (Bouchard et al., 2013)
MV 4 × 6 Gy D2A1/FUCCI mammary ca intravenous 1 (Bouchard et al., 2013)
125 kV 20 Gy AT1 mammary ca mammary f.p. 6d HIF/KITL (Kuonen et al., 2012b)
125 kV 20 Gy AT1 mammary ca mammary f.p. 8b
125 kV 20 Gy AT1 mammary ca mammary f.p. 6
Thorax
300 kV 10 Gy MMT/PyVmT mammary ca intravenous 4 TGFβ (Biswas et al., 2007)
300 kV 10 Gy MMT/PyVmT mammary ca mammary f.p. 17c TGFβ (Biswas et al., 2007)
300 kV 10 Gy MMT/PyVmT mammary ca mammary f.p. 17 TGFβ (Biswas et al., 2007)
60 Co 1 × 15 Gy TS/A mammary ca intravenous 2.5 (Klein et al., 2016)
60 Co 1 X15 Gy B16/F10 melanoma intravenous 2.3 uPA;CCL2
Partial lung
220 kV 10 Gy 4 T1 mammary ca mammary f.p. 3 (Feys et al., 2015)
Abdomen
6 MeV 2 Gy CT26 colon ca intravenous > 1 (Timaner et al., 2015)
Total Body
60 Co 10 Gy B16/F10 melanoma subcutaneous 2 (Klein et al., 2016)
Tumor
250 kV 10 × 0.6 Gy KLN-205 sarcoma subcutaneous 1a (Baker et al., 1981)
137 Cs 5 × 10 Gy LLC-LM lung ca subcutaneous 10 (Camphausen et al., 2001)
137 Cs 5 × 10 Gy T241 fibrosarcoma subcutaneous 14 angiosatin (Camphausen et al., 2001)
6 MV 8 Gy ALT-S1C1 glioma intracranial 0.7 (Wang et al., 2013)
60Co 5 × 10 Gy LLC-M lung ca subcutaneous 5 MMP9 (Chou et al., 2012)
Xenogeneic
Cancer cells
60Co 7.5 Gy HepG2 Hepatoma intrahepatic 3d MMP9 (Cheng et al., 2006a)
60Co 4 Gy CHO1 Fibrosarcoma intravenous 5 (Hamalukic et al., 2011a)
MV 6 Gy CaSki Cervical ca intravenous 1.6 Ras (Su et al., 2012)
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Table 3 Effect of radiation on local invasion or metastasis of rodent and human cancer cell lines as tested in syngeneic and in
xenogeneic mice respectively (Continued)
Radiation Inoculum Score (Ir/Ctrl) Molecular Ref
Target Mode Dose Code Origin Site
MV 2 Gy HT1299 Lung ca intravenous 6a CXCR4 (Gu et al., 2015a)
Inoculation site
220 kV 20 Gy R18 Melanoma intradermal 2b O2/uPAR (Rofstad et al., 2005)
220 kV 20 Gy D12 Melanoma intradermal 2 O2/IL8 (Rofstad et al., 2005)
220 kV 20 Gy SCCVII Oral ca subcutaneous 3.5 CYR61; αvβ5 (Monnier et al., 2008)
220 kV 20 Gy HCT116 Colon ca subcutaneous 4
Total body
6 MV 0.3 Gy 4 T1 mammary ca mammary f.p. 7 VEGFR (Sofia Vala et al., 2010)
6 MV 0.3 Gy MOLT4 leukemia intravenous 5
Tumor
220 kV 10 Gy R18 Melanoma intradermal 1.6b O2/uPAR (Rofstad et al., 2004)
250 kV 2 × 4 Gy U251 glioma intracranial > 1d MMP2 (Badiga et al., 2011)
60Co 5 × 10 Gy C6L glioma subcutaneous > 1a EMT (Park et al., 2012)
nm 5 × 2 Gy FCT133 Thyroid ca subcutaneous 1.6 PI3K (Burrows et al., 2013)
nm 20 Gy 4 T1 mammary ca mammary f.p. 5e (Vilalta et al., 2014)
6 MeV 2 Gy SW480 Colon ca intracolonic > 1a (Timaner et al., 2015)
X-rays 15 × 2 Gy SGC7901 Gastric ca subcutaneous 2 (Zhang et al., 2015a)
Scores indicate the metastasis in the lungs unless indicated as: a, lung and other metastases; b, lymph node metastasis; c, circulating tumor cells (CTC); d, Local
invasion; e, self-seeding from an unirradiated heterolateral breast tumor to an irradiated recipient one. Scores represent metastasis after administration of
radiation relative to control mice (Ir/Ctrl). Abbreviations; avb3, integrin; CAF, cancer-associated fibroblasts; C-ion, carbon-ions; Ca, carcinoma; CAF, cancer-
associated fibroblasts; CCL2, C-C motif chemokine ligand 2; CM, conditioned medium; Co, cobalt; COX-2, cyclooxygenase-2; Cs, cesium; CTC, circulating tumor
cells; CXCL12, C-X-C motif chemokine 12; CXCR4, C-X-C chemokine receptor type 4; CYR61, Cysteine-rich angiogenic inducer 61; EMT, epithelial-to-mesenchymal
transition; f.p., fat pad; Gy, gray; HIF, hypoxia-inducible factor; IGFR, insulin-like growth factor receptor; IL, interleukin; KITL, tyrosine-kinase receptor encoded by
the KIT locus, also known as stem cell factor; Met, tyrosine-protein kinase Met; MMP, matrix metalloproteinases; nm, not mentioned; PI3K, phosphatidylinositol
3-kinase; Ras, small GTPase encoded by the RAS gene; sa, sarcoma; TGF-b, transforming growth factor beta; uPAR, urokinase-type plasminogen activator receptor;
VEGFR, vascular endothelial growth receptor
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cleave off growth factors from their precursors, e.g. prote-
ases activate TGF-β through cleavage from its inactive
precursor latency-associated peptide (LAP-β1). Both en-
zymatic activities are enhanced by ionizing radiation,
explaining stimulation of invasion and metastasis-related
cellular activities (Tables 2 and 3). Irradiation enhanced ac-
tivity of MMP9 is explained by enhanced transcription via
NF-κB (Park et al., 2006a; Cheng et al., 2006a). Irradiation-
enhanced MMP2 promoter activity, mRNA transcription,
and protein secretion associated with invasiveness was ob-
served in glioma cells lacking functional PTEN (U87,
U251, U373, and C6) but not in those harboring wild-type
PTEN (LN18 and LN428) (Park et al., 2006a; Cordes et al.,
2003). This is in contrast with the observations of Wild-
Bode et al. who reported upregulated expression of MMP2
and MT1-MMP, downregulated expression of TIMP-2,
and increased invasiveness in glioma cells regardless of
PTEN status (Wild-Bode et al., 2001). In LLC-LM murine
lung cancer cells, irradiation prompted increased expres-
sion of mRNA and protein as well as increased enzymeactivity for MMP9 but not for MMP2 (Chou et al., 2012).
These researchers also observed that the administration of
5 × 10 Gy to the subcutaneous tumor in the thigh en-
hanced the MMP9 level, stimulated entry of cancer cells
into the circulation and increased the number of pul-
monary metastasis, whereas 2 × 30 Gy reduced these
parameters. Implication of the β-catenin/TCF signal-
ing pathway links MMP to the EMT phenotype. In
U87 glioma cells, irradiation increased the β-catenin/
TCF transcriptional activity, followed by an upregula-
tion of its downstream genes, MMP2, and MMP9
(Dong et al., 2015a). Interestingly, irradiation-induced
overexpression of growth arrest and DNA damage in-
ducible protein alpha (Gadd45a) inhibits the nuclear
translocation of β-catenin, resulting in a downregula-
tion of MMP9, an increase in E-cadherin and a de-
layed medulloblastoma tumor development (Asuthkar
et al., 2011). Other hydrolases are also involved in
irradiation-induced invasion, e.g. the activation of the
serine protease uPA in pancreatic cancer cells via
carbon-ion irradiation (Fujita et al., 2014a).
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from LAP-β1 is an extracellular process, that occurs
rapidly (within 24 h), persistently (7 days) and dose-
dependently (from 0.1 Gy to 5 Gy) upon irradiation of
the mouse mammary gland (Ehrhart et al., 1997). Such
activation results from ROS-induced oxidation of LAP-
β1 triggering a conformational change that releases
TGF-β1. A methionine residue at amino acid position
253 unique to LAP-β1 is critical to this ROS-mediated
activation (Jobling et al., 2006). Circulating levels of
TGF-β were increased in a mouse model of irradiation-
enhanced metastatic breast cancer, regardless of the site
of irradiation: thorax, pelvis or primary tumor and be-
fore or after injection of the cancer cells. In this experi-
ment, circulating cancer cells did not grow ex vivo in
the presence of the TGF-β antibody and irradiation
failed to enhance lung metastases in mice bearing tu-
mors that lacked the type II TGF-β receptor, suggesting
that the increase in metastases was due to a direct effect
of TGF-β on the cancer cells (Biswas et al., 2007).
Heterotypic cell-cell adhesion Heterotypic cell-cell
adhesion, implicated in extravasation and metastasis, is
facilitated by irradiation-triggered expression of cell ad-
hesion factors such as E-selection and vascular cell adhe-
sion protein (VCAM) on cancer cells and endothelial
cells (Hamalukic et al., 2011). Also cell-substrate adhe-
sion is enhanced by irradiation as quantified by the
number of cells that resist washing after seeding and in-
cubation on tissue culture plastic substrate coated with
elements from the extracellular matrix (Tsutsumi et al.,
2009; Nalla et al., 2010; Akino et al., 2009; Cordes et al.,
2003; Jung et al., 2007; Ogata et al., 2005).
The type of extracellular matrix influenced clonogenic
survival of some glioblastoma cells with irradiation-
enhancement on fibronectin or Matrigel, but not bovine
serum albumin (Cordes et al., 2003). For irradiation-
enhanced cell-substrate adhesion, little or no difference
was found between collagen 1, fibronectin, vitronectin
or laminin (Akino et al., 2009; Ogata et al., 2005; Lee
et al., 2010). Irradiation-enhanced cell-substrate adhe-
sion and wound-healing migration could be obtained
only when the tissue culture substrate was coated with
collagen 1 (Tsutsumi et al., 2009).
The pro-invasive effect of fibroblasts on pancreatic
cancer cells has been ascribed to hepatocyte growth fac-
tor (HGF) secreted by the fibroblasts and interacting
with the tyrosine-protein kinase Met (c-MET) on the
cancer cells by Ohuchida et al. (Ohuchida et al., 2004),
and to the ubiquitous and polyfunctional chemokine
CXCL12 interacting with CXCR4 on the cancer cells by
Li et al. (Li et al., 2016a) HGF was put forward because
of the activation of c-MET in pancreatic cancer cells ex-
posed to irradiated fibroblasts and neutralization of thiseffect by NK4 (an antagonist of HGF), although increased
release of HGF from the fibroblasts could not be demon-
strated. CXCL12 was selected because it emerged as the
most elevated species among the irradiation-enhanced
levels of chemokine mRNA. To confirm, Li et al. showed
that addition of CXCL12 to the co-culture stimulated
invasion, whereas the CXCR4 partial agonist AMD3100
reduced it. CXCL12 together with macrophage migration
inhibitory factor (MIF) were chosen also to explain stimu-
lation of adhesion and trans-endothelial migration of hu-
man breast cancer cells by irradiation of lung cells on the
basis of a high fold change found in a 52 cytokine secre-
tome assay (Li et al., 2016a). These pro-invasive cellular
activities were largely mimicked by recombinant CXCL12
and MIF, whereas an allosteric inhibitor of the CXCR4
receptor prevented these activities (Feys et al., 2015).
In summary, irradiation might stimulate motility and
invasion on various different levels. This effect seems to be
dependent on dose, cell line and type of irradiation (pho-
tons versus heavy ions), and was sometimes only transient.Metastasis
To analyze the mechanisms of metastasis, cancer cells
were inoculated at various sites, orthotopic or paratopic,
in immunosuppressed or syngeneic hosts (Table 3), pro-
ducing models that are more readable than the natural
situation at the risk of being less relevant. Similarly,
manipulation of the target and the time of radiation fa-
cilitates dissection of mechanism at the price of lower
relevance. In this way an increase in the metastatic po-
tential has been observed upon radiation of the cancer
cells or of the host, be it on the site of inoculation, puta-
tive sites of metastasis or whole body, prior to transfer
of cancer cells. Also the intravenous inoculation of
radio-resistant cancer cells that were sub-cultured for
several passages after irradiation yielded an increased
metastatic potential (Su et al., 2012). The transfer of
cancer cells into preirradiated host tissue is a model of
recurrent primary tumors in humans. This model has
proven the tumor bed effect, a phenomenon which was
originally described as a prolonged latency period and a
reduced volumetric growth rate of tumors implanted in
previously irradiated tissue and was later extended to an
increased metastatic potential of tumors in preirradiated
beds (Stenstrom et al., 1955; Milas et al., 1988; Rofstad
et al., 2005). For instance, irradiation of the intradermal
inoculation site in nude mice caused enhanced lung
metastasis from human melanoma tumors (Rofstad et al.,
2005) and irradiation of the mammary fat pad of syngen-
eic mice 24 h before inoculation of D2A1 breast cancer
cells enhanced invasion, CTCs and lung metastasis upon
orthotopic but not upon intravenous inoculation
(Bouchard et al., 2013).
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contradictory results have been noted. On the one hand,
Travis et al. observed that irradiation of the whole lung
(14,5 or 20 Gy) after the subcutaneous growth of sar-
coma F tumors in CBA mice led to a decrease in lung
metastases (Travis et al., 1981). On the other hand, sev-
eral others have reported an increase in lung metastases
after irradiation of the lungs prior to subcutaneous injec-
tion of TS/adenocarcinoma cells or B16 melanoma cells
or prior to intravenous injection of B16 melanoma cells,
TS/adenocarcinoma cells (Klein et al., 2016), fibrosar-
coma cells (Withers & Milas, 1973), mammary carcin-
oma cells (Dao & Yogo, 1967), Ehrlich ascites cells
(Tanaka, 1976) or Walker tumor cells (Fisher & Fisher,
1969). Furthermore, Gong et al. reported that in BALB/c
mice, irradiation of the right side of the chest to 9 Gy
after injection of 4T1 mammary carcinoma tumor cells
in the right last mammary gland led to higher incidence
of lung metastasis and a shorter survival (Gong et al.,
2015). Interestingly, Feys et al. observed enhanced lung
metastasis from orthotopic 4T1mouse mammary tumors
after partial right lung irradiation, but not after whole
thorax irradiation (Feys et al., 2015). Also irradiation of
the liver has been reported to lead to an increase in liver
metastases after the intraportal inoculation of Ehrlich asci-
tes carcinoma cells (Fisher & Fisher, 1969; Koike et al.,
1962). Several hypotheses of this pro-metastatic effect of
radiotherapy on the putative site of metastasis have been
formulated. (a) Circulating tumor cells might be attracted
to the irradiated tissue. (b) Cancer cell release from the
primary tumor might be stimulated. (c) Irradiation could
instigate local immune changes leading to the recruitment
of several immune cells from the innate and adaptive im-
mune system, which can produce paracrine signals facili-
tating tumor survival and growth (Feys et al., 2015; Gong
et al., 2015). These immune cells can however also stimu-
late an antitumor immune response, which is therefore
not in line with the previously discussed observations. (d)
Irradiation could damage vascular endothelial cells which
enables the transmigration of tumor cells through the
endothelium (Klein et al., 2016).
Via bioluminescence it was proven that irradiation
of the primary breast tumor increases the homing of
donor tumor cells to this site and therefore enhances
self-seeding (Vilalta et al., 2014). Timaner et al.
showed in mice that not only local irradiation of the
tumor with 2 Gy will cause an increase in metastases,
but also that irradiation (2 Gy) of the abdomen, prior
to intravenous injection of CT26 colon cancer cells
into the tail vein leads to higher mortality due to pul-
monary metastases (Timaner et al., 2015). This find-
ing indicates that irradiation can instigate a systemic
host response that enhances migration and invasion
of tumor cells.Delivery of an ablative dose to the primary tumor and
a subsequent increase in lung metastases as compared
to no irradiation of the primary tumor led Camphausen
et al. to conclude that metastases are present in a
dormant form at the moment of irradiation, similar to
the experiments in which the same type of tumors were
removed surgically (Camphausen et al., 2001; O'Reilly
et al., 1994). With a subtherapeutic dose, irradiation-
enhanced metastasis was observed only after regrowth
of the primary tumor, leading to the conclusions that
irradiation stimulated metastasis from the primary
tumor (Rofstad et al., 2005).
An overview of the communication within the cancer
ecosystem regarding invasion and metastasis is depicted
in Fig. 2. The molecular pathways implicated in the
process of radiation-enhanced invasion and metastasis is
depicted in Fig. 1. There is large and convincing preclin-
ical evidence in favor of a prometastatic activity of radi-
ation with very few scores lower than zero (seventh
column in Table 3), pointing to inhibition. Furthermore,
in vitro and in vivo experiments have revealed a profu-
sion of molecular pathways implicated in radiation-
enhanced invasion and metastasis (Fig. 1), several of
which are sensitive to inhibition by molecules that are
clinically applicable (Table 2). The crucial question is:
how do these experimental findings translate to the
clinical situation?
Clinical evidence
Preclinical evidence on how irradiation influences the
metastatic process is conflicting, and in vitro and in vivo
experiments are often not a good representation of the hu-
man situation. Furthermore, the potential pro-metastatic
effect of radiotherapy is hard to infer from the literature
due to lack of attention to metastasis in palliative cases,
heterogeneity of the cohorts analyzed, lower sensitivity or
specificity of methods of detection, lack of systematic
autopsy and weak study designs. Nonetheless, clinical
evidence exists that certain cancer therapies produce pro-
metastatic and pro-invasive signals.
Chung et al. analyzed a cohort of 340 patients with
unresectable hepatocellular carcinoma (T3N0M0) who
received either transcatheter arterial chemoembolization
alone or in combination with radiotherapy (40–66 Gy in
1.8 to 2 Gy fractions). Although the study was not
randomized, baseline patient characteristics and treat-
ment variables did not differ significantly between both
groups. Overall survival was similar in both groups, yet
the group treated with radiotherapy quickly developed
intra- and extrahepatic tumors outside the irradiation field
resulting in a significantly shorter extrahepatic progression-
free survival (Chung et al., 2006). The smaller study by
Cheng et al. had similar findings (Chia-Hsien Cheng et al.,
2001). A mechanism postulated is the irradiation-induced
Fig. 2 Schematics of mutual communication between cancer cells, tumor associated host cells and ecosystems. a Schematic of communication
between cancer cells and tumor-associated host cells with invasion-related radiation-sensitive molecules. Arrows indicate the communication
between cancer cells and tumor-associated host cells, namely fibroblasts, macrophages, lymphocytes, adipocytes, osteoclasts and endothelial
cells, and between tumor-associated host cells, for example fibroblasts to endothelial cells. White text boxes overlapping the arrows contain the
molecules implicated in this communication and shown to be sensitive to alterations by radiation. This intercellular communication establishes
the individual local ecosystems that participate at metastasis as shown in panel b Adapted from Mareel et al., (2009b), with data from: Vakaet (2004);
Abdollahi (2005); Chargari et al., (2013); De Bacco et al., (2011b); Gu et al., (2015b); Hamalukic et al., (2011b); Hirschhaeuser et al., (2011); Kuonen et al.,
(2012a); Li et al., (2016b); Madani et al., (2008); Nubel (2004); Vilalta (2016); Lee et al., (2017c). b Schematic of the communication between ecosystems
of primary tumor, distant metastasis, lymph node and bone marrow, associated with metastasis and sensitive to ionizing radiation. Arrows indicate the
communication between ecosystems, namely the primary tumor, lymph node, distant metastasis and bone marrow. Participating at this communication
are host cells (smaller green ovals), cancer cells (smaller pink ovals) and molecules (white text boxes), all implicated in radiation-enhanced metastasis.
Adapted from: Madani et al., (2008); Ceelen et al., (2014) and Willaert et al., (2014) with data from: Kioi et al., (2010b); Kuonen et al., (2012c); Russell & Brown
(2013b); Vilalta (2016). Abbreviations: CC, cancer cells; CCL, C-C motif chemokine ligand; CSF1, macrophage colony-stimulating factor 1; CTC, circulating
tumor cells; CXCL, C-X-C motif chemokine ligand; DC, dendritic cells; DTC,disseminated tumor cells; EPC, endothelial precursor cells; FGF2, basic fibroblast
growth factor; GMCSF, granulocyte-macrophage colony-stimulating factor; HGF, hepatocyte growth factor; HSC, hematopoietic stem cells; IGF1, insulin-
like growth factor 1; IL, interleukin; LC, lymphocytes; MCC, metastatic cancer cells; MMP, matrix metalloproteinase; MSC, mesenchymal stem cells; OPN,
osteoprotogerin; PDGF, platelet-derived growth factor; PlGF, placental growth factor; RANKL, receptor activator of nuclear kappa-B ligand; SC, stem cells;
S-Lewis A, sialyl-Lewis A antigen; SCF, stem cell factor; SDF1 (also called CXCL12), stromal- cell derived factor 1; sVCAM1, soluble vascular cell adhesion
molecule 1; TGFβ, transforming growth factor beta; TNFα, tumor necrosis factor-alpha; VEGF, vascular endothelial growth factor
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genesis (Chung et al., 2006). In line with these findings,
in 12 of 16 stage III rectal cancer patients, upregulation
of VEGF was shown immunohistochemically on theresection specimen after neo-adjuvant radiochemother-
apy (Nozue et al., 2001).
In a prospective randomized trial, patients with oro-
and hypopharyngeal squamous cell carcinoma were either
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followed 3 days later by surgery. No difference in survival
was seen, yet the group treated with radiotherapy had a
higher incidence of distant metastases at time of death
(Strong et al., 1978). Other non-randomized studies in
head and neck cancer reported more distant metastases in
the radiotherapy groups; yet selection bias could be the
cause of this difference (Merino et al., 1977; Schantz &
Peters, 1987).
These findings bring forth the hypothesis that the
beneficial local effects of radiotherapy are counteracted
by its systemic pro-invasive and pro-metastatic effect
and therefore does not lead to an increased overall
survival. The fact that the appearance of distant metasta-
sis has been unchanged in the field of head and neck
squamous cell carcinoma over the last decades, notwith-
standing new radiotherapy and chemotherapy, supports
this hypothesis (Duprez et al., 2017). The addition of
molecules blocking this systemic pro-invasive and pro-
metastatic effect could therefore entail a survival benefit,
examples of these molecules are denoted in Table 2. The
combination of radiotherapy with targeted molecules
has been previously reviewed by Maier et al. (Maier
et al., 2016).
Furthermore, it has been shown that radiotherapy
and chemotherapy can alter the metastatic pattern as
compared to no treatment. De La Monte et al. found
that the distribution of metastases of small cell lung
carcinoma was different after radiotherapy, chemo-
therapy or no therapy, but with similar number of
total distant metastases and similar overall survival in
all groups. These cancer treatments therefore might
instigate a growth advantage to certain subpopula-
tions of the tumor, which metastasize to specific sites
(de la Monte et al., 1988).
Radiotherapy can also induce a local pro-invasive ef-
fect, as shown predominantly in breast cancer but also
in nasopharyngeal and endometrial cancer, in which
inflammatory skin recurrence, exactly demarcating the
previously irradiated area, occurred (Tsujino et al., 2011;
Meltzer et al., 1981; Marley & Marley, 1982). This
phenomenon is rare and its incidence in breast cancer is
estimated at 0.25%. The mechanism inducing it is not
understood, yet radiotherapy could change the local
microenvironment, facilitating tumor cells to migrate
into this area (Tsujino et al., 2011).
In line with this, radiotherapy of prostate cancer and
rectal cancer can increase MMP activity in the tumor
and the local microenvironment (Angenete et al., 2009;
Hovdenak et al., 2002; Kumar et al., 2002; Kumar et al.,
2000). As stated above, these MMPs play a crucial role
in invasion (Brown & Murray, 2015) and are correlated
with cancer stage, metastasis and survival (Cho et al.,
2005; Trudel et al., 2010).Evidently, radiotherapy can also yield an anti-invasive
and anti-metastatic effect. Post-mastectomy radiotherapy
in high-risk breast cancer patients leads to a significantly
lower probability of locoregional recurrences and distant
metastases (Nielsen et al., 2006; Poortmans et al., 2015).
Furthermore, several pre-clinical and clinical data indi-
cate that radiotherapy can instigate a systemic anti-
tumor effect in non-irradiated metastases, yet this effect
is extremely rare and impossible to predict (Abuodeh
et al., 2016; Formenti & Demaria, 2009). The underlying
mechanism could be a radiotherapy-induced systemic
anti-tumor immune response (Formenti & Demaria,
2009). The systemic anti-tumor effect of radiotherapy
was described for the first time by Mole in 1953 and was
termed the ‘abscopal effect’ (Mole, 1953). Recently, it has
been more frequently reported, often when radiotherapy
was administered in combination with checkpoint-
inhibitors (Postow et al., 2012). Small prospective studies
and retrospective studies have shown that the combination
of checkpoint-inhibitors with radiotherapy could act syn-
ergistically, raising response rates and improving survival
(Shaverdian et al., 2017; Twyman-Saint Victor et al., 2015;
Hiniker et al., 2016; Williams et al., 2017; Tang et al., 2017;
Sundahl et al., 2018). The underlying molecular mechan-
ism could be the release of tumor antigen, triggered by
radiotherapy-induced immunogenic cell death, and a sub-
sequent systemic anti-tumor immune response, mediated
by the checkpoint-inhibitor which reactivates the immune
system by blocking the inhibitory signals on the immune
cells (e.g. programmed cell death protein 1) (Formenti &
Demaria, 2009). Several prospective clinical trials are cur-
rently investigating this combination treatment (Vacchelli
et al., 2016; Sundahl et al., 2017; De Wolf et al., 2017).
Conclusion
There is abundant evidence from in vivo and in vitro ex-
periments that ionizing radiation, applied to cancer cells
or host cells, to the tumor, the whole host or the putative
site of tumor development may stimulate the metastatic
process. Clinical observations do not directly confirm
these data, leaving open the question whether or not
radiotherapy enhances metastasis. The overall net out-
come of radiotherapy is beneficial as it may reduce metas-
tasis and prolong survival. This therapeutic benefit does
not exclude a limitation of the benefit by negative effects
of the irradiation on the cancer cells or on the host. The
present review of literature suggests clinical trials to inves-
tigate correction of the pro-invasive and pro-metastatic
activities of radiation by anti-inflammatory or other agents
shown to be effective in preclinical settings.
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